Your blood report uses the wrong reference ranges.

You get your annual bloodwork back. Almost everything is in range. The little flags next to each marker are reassuringly absent. Your doctor glances at it for thirty seconds and says, "Looks fine, see you next year."

And yet you're tired by 3pm, your weight has crept up despite no change in diet, and your sleep isn't what it was. Nothing on the page explains it, because the page was never designed to.

The problem isn't your blood. It's the reference range, the little "normal" interval printed next to each number. Almost nobody, including a lot of clinicians, stops to ask where that range comes from. When you do, the whole report reads differently.

What "normal" actually means on a lab report

A reference range is built by taking a large sample of people, measuring a marker, and reporting the middle 95% of the results. The top and bottom 2.5% get cut off, and whatever's left becomes "normal."

Read that again, because the implication is the part nobody mentions: the reference population includes everyone who got that test done. People with early metabolic disease. People with undiagnosed deficiencies. People whose health is quietly deteriorating but haven't been flagged yet. They're all in the dataset that defines "normal."

"Normal" is not "healthy." It's "statistically common among people who happened to get a blood test." Those are very different things.

This matters most in populations where dysfunction is widespread. If a marker is drifting in the wrong direction for a large share of the tested population, the "normal" range drifts with it. The bar moves to meet the crowd, and the crowd isn't well.

Normal vs optimal: a different question

There's a second range that almost never appears on your report: the optimal range. This isn't "what's common." It's "what's associated with the lowest risk of future disease", drawn from outcome studies that followed people for years and asked which values predicted who stayed healthy.

The two ranges can be strikingly far apart. A few examples where the gap routinely catches people out:

Look at fasting insulin. You can sit at 14 µIU/mL, comfortably "normal", while your body is already fighting insulin resistance that, on a risk basis, started years ago. Your report will never flag it. The standard panel often doesn't even measure it; it stops at glucose and HbA1c, both of which move late, long after insulin has been quietly climbing.

This is the single most common way a report says "fine" while the biology says otherwise: the marker that would have caught the problem early either isn't measured, or is judged against a bar set far too low.

Then there's the South Asian problem

Now add a third layer. Most reference ranges in widespread use were built on largely European-ancestry populations. South Asian bodies don't always behave the same way, and in metabolic health, the differences are not subtle.

South Asians develop insulin resistance and type-2 diabetes earlier and at lower body weight than white Europeans. Cardiovascular risk runs higher at a given LDL. Body-fat distribution skews more visceral at the same BMI. A "normal" calibrated on a different population can wave through a South Asian person who is, by their own physiology, already in trouble.

A reference range built for one body, applied to another, doesn't become wrong loudly. It becomes wrong silently, which is worse.

This is why two people with identical lab values can be at genuinely different risk, and why "your numbers are normal" is an incomplete sentence. Normal by which range, built on whom?

What to actually do with this

You don't need to distrust your doctor or your lab. You need to read the report with three questions instead of one:

• Is this marker even measured? The early-warning markers, fasting insulin, ApoB, hs-CRP, ferritin, full thyroid, are routinely left off standard panels. A clean report on an incomplete panel tells you very little.
• Normal, or optimal? For anything in the "low-normal" or "high-normal" zone, ask where it sits against the risk-based range, not just the population range.
• Calibrated for whom? Especially for metabolic and cardiovascular markers, a South Asian body deserves a South Asian-aware read.

None of this requires exotic testing. It requires interpreting ordinary markers against the right bar, the one tied to long-term outcomes, for a body like yours. That shift, from "any flags?" to "how close to optimal, for me?", is most of the value in reading your own bloodwork well.